Frankfurt - Delayed Quote • EUR United Therapeutics Corporation (UTH.F) Follow Add holdings 268.60 +3.30 +(1.24%) As of 8:01:02 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for UTH.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: UTH.F View More All News Press Releases SEC Filings Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses UTHR Q1 Earnings Call: Double-Digit Growth Continues, Pipeline Expansion Remains Central Is United Therapeutics (UTHR) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies? Liquidia Corp (LQDA) Q1 2025 Earnings Call Highlights: Strategic Advances and Legal Wins Propel ... 3 Big Reasons to Love United Therapeutics (UTHR) Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks Therapeutics Stocks Q1 Results: Benchmarking Sarepta Therapeutics (NASDAQ:SRPT) 3 Market-Beating Stocks with Solid Fundamentals Earnings To Watch: Sarepta Therapeutics (SRPT) Reports Q1 Results Tomorrow United Therapeutics First Quarter 2025 Earnings: Beats Expectations UTHR Q1 Earnings & Revenues Beat Estimates on Higher Tyvaso Sales